A diversity of knowledge & disciplines
Our strong advisor and partner network brings together the best and brightest across sectors to develop the groundbreaking NGP technology ready to transform the treatment of Infectious Diseases.
Clinical
Commercial
Scientific
Stewardship
Steadfast support
Selux Diagnostics is supported by a successful public and private sector collaboration to solve one of the world's toughest health challenges.
Selux Diagnostics NGP platform has received a total of $30.4 million in funding from the U.S. Department of Health and Human Services (HHS); Office of the Assistant Secretary for Preparedness and Response (ASPR); and the Biomedical Advanced Research and Development Authority (BARDA)
Acknowledgment: This platform has been funded in whole or part with federal funds from the U.S. Department of Health and Human Services (HHS); Office of the Assistant Secretary for Preparedness and Response (ASPR); and the Biomedical Advanced Research and Development Authority (BARDA), under Contract No. HHSO100201800013C.